All patients undergoing CRRT while on ECLS between 2005 and 2010 at Seattle Children's Hospital (n = 42) were identified by a retrospective review of a prospectively maintained institutional database.

Nicklaus Children's Hospital has acquired Mozarc Medical's Carpediem™ Cardio Renal Pediatric Dialysis Emergency Machine ...

Carpediem offers a miniaturised platform and enhances the precision of neonatal continuous renal replacement therapy.

Because CRRT solutions contain potassium chloride and other electrolytes, are considered high-alert medications, and are complex to prepare, these solutions were targeted as a source of potential ...

To provide medical professionals (RN, MD, Pharmacist) with the knowledge and understanding for decision making for the effective utilization of Continuous Renal Replacement Therapy (CRRT) and to allow ...

Albeit negative, the results from the RENAL and ATN trials can inform clinical practice. The studies show that survival rates can be just as good when the delivery of CRRT is 19–22 ml/kg per ...

A recent meta-analysis concluded that continuous renal replacement therapy (CRRT) is not superior to intermittent renal replacement therapy (IRRT) in terms of hemodynamic control, renal recovery ...

Under the direction of the Yogi government, devotees are being offered high-level health facilities during the Mahakumbh fair ...

View original content to download multimedia:https://www.prnewswire.com/news-releases/calcimedica-announces-upcoming-plenary-presentation-at-the-30th-international ...

Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.

CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition ...

Thermo Fisher Scientific and Sony are among the stocks that fell into undervalued territory. Maintaining independence and editorial freedom is essential to our mission of empowering investor ...